CN Patent
CN101132776A — 稳定的四氢生物喋呤片剂制剂
Assigned to Biomarin Pharmaceutical Inc · Expires 2008-02-27 · 18y expired
What this patent protects
本发明涉及稳定的四氢生物喋呤固体制剂,其制备方法以及使用所述制剂进行治疗的方法。
USPTO Abstract
本发明涉及稳定的四氢生物喋呤固体制剂,其制备方法以及使用所述制剂进行治疗的方法。
Drugs covered by this patent
- Sephience (SEPIAPTERIN) · Ptc Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.